Inclusive of all taxes
Tranexamic Acid Injection BP (100mg/ml) offered by Ancalima Lifesciences Limited is a high-quality antifibrinolytic agent formulated according to the British Pharmacopoeia (BP) standards. This injectable solution comes with a strength of 500mg per 5ml ampoule, delivering a concentration of 100mg/ml, explicitly designed to effectively prevent excessive bleeding by inhibiting fibrinolysis. The product is supplied in a convenient tray pack containing 5 ampoules, each with 5ml of sterile solution, ideal for hospital and clinical use. Its precise dosage form ensures rapid and controlled administration, making it essential in surgical, trauma, and various bleeding disorder treatments. Manufactured under stringent quality control, this Tranexamic Acid injection ensures consistent therapeutic efficacy, safety, and reliability for healthcare professionals.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Tranexamic Acid |
| Concentration | 100mg/ml |
| Strength | 500mg/5ml |
| Dosage Form | Injection (Solution) |
| Pharmacopeia Standard | British Pharmacopoeia (BP) |
| Therapeutic Category | Antifibrinolytic agent |
| Packaging | Tray Pack of 5 Ampoules |
| Ampoule Volume | 5ml per ampoule |
| Storage | Store below 25°C, protect from light |
| Attributes | Description |
|---|---|
| Active Substance | Tranexamic Acid |
| Concentration | 100mg per ml |
| Total Strength | 500mg per ampoule (5ml) |
| Dosage Form | Injection Solution |
| Compliance | British Pharmacopoeia (BP) |
| Packaging Type | Ampoule |
| Pack Size | Tray pack of 5 ampoules |
| Intended Use | Treatment of bleeding disorders and surgical bleeding |
| Shelf Life | Refer to manufacturer's details |
| Storage Instructions | Store in a cool, dry place below 25°C, avoid light exposure |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
The injection has a concentration of 100mg/ml and a total strength of 500mg per 5ml ampoule.
It is supplied in a tray pack containing 5 ampoules, each ampoule having 5ml of solution.
This product is manufactured according to the British Pharmacopoeia (BP) standards.
It is intended for use as an antifibrinolytic agent to prevent excessive bleeding during surgery or bleeding disorders.
The injection should be stored below 25°C, protected from light, in a cool and dry place.
Country Of Origin: India
Tranexamic Acid Injection BP is a biocompatible injectable formulation designed to inhibit fibrinolysis and stabilize clot formation. The 100mg/ml concentration ensures precise dosing for clinical hemostatic interventions.
This standardized dosage supports rapid hemostatic control, making it suitable for surgical, trauma, and institutional applications.
The formulation contains pharmaceutically pure tranexamic acid dissolved in sterile isotonic medium with stabilizers to maintain chemical integrity and solubility. This ensures accurate dosing and long-term stability for clinical use.
The low-viscosity injectable provides smooth systemic administration, rapid hemostatic action, and predictable pharmacokinetics. Shelf-stable under controlled conditions, it allows for repeatable therapeutic performance.
Used widely in hospitals, surgical centers, and trauma care, this injection is suitable for bulk sourcing, OEM supply, and export-ready pharmaceutical operations. Its standardized 100mg/ml dosage ensures reliable performance in professional B2B markets requiring precise hemostatic intervention.
Inclusive of all taxes
You Save: 0
